Its 52 week high is $0.0819 reached on April 12, 2021. The article says it shot up to $0.175 earlier this year. Where did they get $0.175 from?
The stock has a history of explosive moves running to $0.175 earlier this year after the Company and its subsidiary KLS entered into an agreement with Oncology Pharma, Inc. whereby Regen granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property for the treatment in humans of pancreatic cancer for a term of fifteen years from April 7, 2021.